-
-
-
-
-
-
-
Kiniksa Pharmaceuticals, Ltd. (KNSA) Misses Q4 EPS by 18c
-
-
-
-
-
-
-
Kiniksa receives orphan drug designation for pericarditis treatment
-
-
-
-
-
-
-
Kiniksa Pharmaceuticals Ltd. (KNSA) Announces Development of KPL-387
-
-
-
-
-
444,219 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

